Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2008
09/12/2008WO2008107479A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
09/12/2008WO2008107399A1 Substituted oxindole compounds
09/12/2008WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008107096A1 Diaminopyrimidines as fungicides
09/12/2008WO2008091580A3 Fungicidal amides
09/12/2008WO2008074824A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/12/2008WO2008070016A3 Inhibitors of akt activity
09/12/2008WO2007117399A3 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
09/12/2008WO2007107594A3 Six-membered heterocycle substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
09/12/2008WO2004078116A9 P38 inhibitors and methods of use thereof
09/12/2008CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2680125A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2-receptor modulators
09/12/2008CA2680120A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
09/12/2008CA2680055A1 Novel 2-heteroaryl substituted indoles 695
09/12/2008CA2679735A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008CA2679670A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
09/12/2008CA2679488A1 Diaminopyrimidines as fungicides
09/12/2008CA2679411A1 Ppar active compounds
09/12/2008CA2679380A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
09/12/2008CA2679305A1 Pyrrole compounds
09/12/2008CA2679249A1 Compounds and compositions as modulators of gpr119 activity
09/12/2008CA2675312A1 1-biarylazetidinone derivative
09/11/2008US20080221327 Synthesis of glyt-1 inhibitors
09/11/2008US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds
09/11/2008US20080221178 Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof
09/11/2008US20080221177 for controlling phytopathogenic harmful fungi
09/11/2008US20080221168 N-Thio-Anthranilamid Compounds and Their Use as Pesticides
09/11/2008US20080221152 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
09/11/2008US20080221151 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors
09/11/2008US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents
09/11/2008US20080221128 Metalloprotease inhibitors containing a squaramide moiety
09/11/2008US20080221124 Cancer drug; due to high solubility of ethanolamine salt in the aqueous phase of reaction mixture, it can be separated from the organic phase with little, no loss of yield; aqueous phase can be charged to hot aqueous acetic acid to crystallize product; poorly filtering polymorphic form is not generated
09/11/2008US20080221118 Tetrahydroquinoline Derivatives
09/11/2008US20080221117 Analgesics; antidiabetic agents;anticancer agents;psychological disorders; schizophrenia; neurodegenerative diseases
09/11/2008US20080221114 (S)-1-(1,3-benzoxazol-2-yl)-2-[[(S)-3-methylpiperidin-1-yl]carbonyl]indoline; for treating/preventing anxiety disorder, depression, epilepsy, dementia; can selectively act on mitochondrial benzodiazepine receptor
09/11/2008US20080221112 New utilities of amide compounds
09/11/2008US20080221101 Calcium receptor modulating agents
09/11/2008US20080221100 Soluble epoxide hydrolase inhibitors
09/11/2008US20080221094 Metalloprotease inhibitors containing a squaramide moiety
09/11/2008US20080221088 3,4-Substituted Thiazoles as Ampk Activators
09/11/2008US20080221087 Substituted lactams as inhibitors of abeta protein production
09/11/2008US20080221086 Novel Inhibitors of Glutaminyl Cyclase
09/11/2008US20080221085 Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases
09/11/2008US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation
09/11/2008US20080221078 Use of a CB1 Antagonist for Treating Side Effects and Negative Symptoms of Schizophrenia
09/11/2008US20080220286 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films
09/11/2008US20080217580 Organic Luminescent Element
09/11/2008US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates
09/10/2008EP1967517A1 Probe for diagnosis of conformational disease
09/10/2008EP1967211A1 Method of producing solid preparation disintegrating in the oral cavity
09/10/2008EP1966193A1 New salt and polymorph of dpp-iv inhibitor
09/10/2008EP1966192A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/10/2008EP1966191A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
09/10/2008EP1966190A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
09/10/2008EP1966189A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
09/10/2008EP1966188A1 Enantioselective preparation of benzimidazole derivatives and their salts
09/10/2008EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
09/10/2008EP1966186A1 Process for the preparation of imatinib
09/10/2008EP1966185A2 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION
09/10/2008EP1966184A2 Pyridinyl-quinazoline derivatives and their medical use
09/10/2008EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/10/2008EP1966171A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
09/10/2008EP1966167A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
09/10/2008EP1966163A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
09/10/2008EP1966159A2 Chemical compounds
09/10/2008EP1966156A2 New compounds iii
09/10/2008EP1966147A1 Carboxamides for controlling micro-organisms in plant and material protection
09/10/2008EP1966144A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
09/10/2008EP1966143A2 Substituted aniline derivatives useful as histamine h3 antagonists
09/10/2008EP1966142A2 New phenanthridine derivatives as bradykinin antagonists
09/10/2008EP1966141A1 Six-membered heterocycles useful as serine protease inhibitors
09/10/2008EP1966139A1 Aspartic protease inhibitors
09/10/2008EP1966137A2 Piperidine derivatives
09/10/2008EP1966134A1 Novel fused pyrrole derivatives
09/10/2008EP1965785A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
09/10/2008EP1646389B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
09/10/2008EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
09/10/2008EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
09/10/2008EP1373396B1 Highly nucleated thermoplastic articles
09/10/2008EP1323710B1 Nitrogenous five-membered ring compounds
09/10/2008CN101263135A Modulators of metabolism and the treatment of disorders related thereto
09/10/2008CN101263134A Midazole-4-carboxamide derivatives for use as CB modulators
09/10/2008CN101263133A New pyridine analogues
09/10/2008CN101263125A Quinazoline derivatives useful in cancer treatment
09/10/2008CN101263124A Quinazoline derivatives useful in cancer treatment
09/10/2008CN101263122A 1,2-diarylimidazoles for use as CB1 modulators
09/10/2008CN101263121A Histone deacetylase inhibitors
09/10/2008CN101263112A Histamine H3 receptor agents, preparation and therapeutic uses
09/10/2008CN101260122A 2-(6'-iminopyridyl)quinoxaline metal complex compound and its preparing method and application
09/10/2008CN101260106A Raf kinase inhibitor, preparing method and use thereof
09/10/2008CN101260075A Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament
09/09/2008US7423159 Agent for preventing or treating neuropathy
09/09/2008US7423157 Substituted benzimidazoles and their use for inducing apoptosis
09/09/2008US7423153 Crystalline forms of gatifloxacin
09/09/2008US7423150 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
09/09/2008US7423148 Small molecule PI 3-kinase inhibitors and methods of their use
09/09/2008US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
09/09/2008US7423058 Inhibitors of hepatitis C virus NS3 protease
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 1080